OPKO Health to Present at the Jefferies 2011 Global Healthcare Conference

MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE Amex: OPK) today announced that senior management will present at the Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011 at 1:15 PM Eastern Time in New York, NY.

OPKO senior management will provide a review of recent corporate developments.

About OPKO Health, Inc.

Miami-based OPKO is a specialty healthcare company involved in the discovery, development, and commercialization of proprietary pharmaceutical and diagnostic products and vaccines. Initially focused on the treatment and management of ophthalmic diseases, OPKO has since expanded into other areas of major unmet medical need.



CONTACT:

OPKO Health, Inc.
Steven D. Rubin, 305 575-6015

KEYWORDS:   United States  North America  Florida

INDUSTRY KEYWORDS:   Health  Biotechnology  Genetics  Infectious Diseases  Medical Devices  Oncology  Optical  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.